Clinical trials

A Phase 2 Study of STC-15 as a Monotherapy in Select Sarcomas (NCT06975293). For more information, please visit clinicaltrials.gov.

Expanded Access

STORM will consider requests from requesting physicians for pre-approval access to STC-15, for the treatment of an individual patient outside of a clinical trial. Physicians seeking pre-approval for patients with no alternative treatment options should submit their requests to expandedaccess@stormtherapeutics.com.